SKI Market

Indian Indices

Nifty

24,971.90 -140.50
(-0.56%)

Sensex

81,896.79 -511.38
( -0.62%)

Bank Nifty

56,059.35 -193.50
( -0.34%)

Nifty IT

38,414.10 -577.35
( -1.48%)

Global Indices

Nasdaq

42,233.20 40.53
(0.10%)

Dow Jones

5,989.55 -12.32
(-0.21%)

Hang Seng

38,330.35 -72.88
(-0.19%)

Nikkei 225

8,774.65 -17.15
(-0.20%)

Forex

USD-INR

86.67 0.24
(0.27%)

EUR-INR

99.45 0.06
(0.06%)

GBP-INR

116.39 0.20
(0.17%)

JPY-INR

0.60 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Beta Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535022

INE351Y01019

127.8259206

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BETA

95.48

1790.77

EPS(TTM)

Face Value()

Div & Yield %

18.58

Back

Aanchal Ispat Ltd - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Apr 05,2025

This is to inform that the Resolution plan submitted by Mr. Mukesh Goel the Successful Resolution Applicant (SRA) for Aanchal Ispat Ltd (AIL) has been approved by the NCLT Kolkata bench. copy of the approval order attached herewith.

24,971.90 -140.50 (-0.56%)

81,896.79 -511.38 ( -0.62%)

56,059.35 -193.50 ( -0.34%)

38,414.10 -577.35 ( -1.48%)

42,233.20 40.53 (0.10%)

5,989.55 -12.32 (-0.21%)

38,330.35 -72.88 (-0.19%)

8,774.65 -17.15 (-0.20%)

86.67 0.24 (0.27%)

99.45 0.06 (0.06%)

116.39 0.20 (0.17%)

0.60 0.00 (-0.02%)